# Evaluating Anatomic Versus Targeted Lead Placement for Burst Stimulation Therapy During the Trial

> **NCT03277378** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 270 (actual)

## Conditions studied

- Chronic, Intractable Pain of the Trunk and/or Lower Limbs

## Interventions

- **DEVICE:** lead placement followed by BurstDR stimulation

## Key facts

- **NCT ID:** NCT03277378
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-22
- **Primary completion:** 2018-08-23
- **Final completion:** 2018-10-12
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2021-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03277378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03277378, "Evaluating Anatomic Versus Targeted Lead Placement for Burst Stimulation Therapy During the Trial". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03277378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*